The Jewel IDE Study

NACompletedINTERVENTIONAL
Enrollment

322

Participants

Timeline

Start Date

January 12, 2022

Primary Completion Date

November 10, 2023

Study Completion Date

November 10, 2023

Conditions
Sudden Cardiac Arrest
Interventions
DEVICE

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)

Automatic external cardioverter defibrillator that monitors patients at risk for SCA and provides a therapeutic shock if needed.

Trial Locations (30)

10467

Montefiore Medical Center, The Bronx

10941

Crystal Run Healthcare - Circuit - PPDS, Middletown

11040

Northwell Health, New Hyde Park

11215

New York Presbyterian Brooklyn Methodist Hospital, Brooklyn

20010

MedStar Georgetown University Hospital, Washington D.C.

21287

Johns Hopkins Hospital, Baltimore

22042

Inova Fairfax Hospital, Falls Church

23225

Virginia Cardiovascular Specialists, Richmond

27103

Novant Health, Winston-Salem

30308

Emory University, Atlanta

30309

Fuqua Heart Center Piedmont Hospital, Atlanta

37203

Saint Thomas Research Institute, Nashville

38104

Methodist Le Bonheur, Memphis

38801

North Mississippi Medical Center, Tupelo

39216

University of Mississippi Medical Center, Jackson

40202

University of Louisville, Louisville

40503

Central Baptist Hospital, Lexington

43210

Ohio State University Wexner Medical Center, Columbus

45242

TriHealth Heart Institute Cardiac and Thoracic, Cincinnati

46845

Parkview Research Center, Fort Wayne

52246

University of Iowa Hospitals and Clinics, Iowa City

60201

NorthShore Medical Group, Evanston

60611

Northwestern University, Chicago

72204

Cardiology and Medicine Clinic, P.A., Little Rock

72401

St. Bernard's Heart and Vascular, Jonesboro

75071

ACRC Trials - Hunt - PPDS, McKinney

77030

Methodist Hospital, Houston

06102

Hartford Hospital, Hartford

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

Sponsors
All Listed Sponsors
lead

Element Science, Inc.

INDUSTRY